7th Dermatology Drug Development Summit Europe 2026

 

The 7th Dermatology Drug Development Summit Europe brings together leading pharma and biotech teams to accelerate clinical progress for small molecules and biologics targeting both rare and common skin diseases.

With late‑stage pipelines expanding across conditions such as atopic dermatitis, psoriasis, hidradenitis suppurativa, and vitiligo, the event focuses on overcoming regulatory hurdles, reducing Europe’s post‑approval access delays, and improving trial design amid high placebo effects.

Offering 3 days of case studies, workshops and over 6 hours of networking time, attendees will gain practical insights into advanced imaging, biomarkers, AI‑enabled trial design, and real‑world evidence strategies. To learn more, continue reading…

More Info

---

---